California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
China’s One-Child Policy Legacy Resurfaces After Death of Former Population Chief 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
U.S. Prioritizes Economic Pressure With Venezuelan Oil Quarantine as Sanctions Intensify 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
Zelenskiy Urges High-Level Talks With Trump as Ukraine, U.S. Near 20-Point Peace Framework 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Japan Approves Record ¥122.3 Trillion Budget as Takaichi Seeks Fiscal Balance 
U.S. Judge Blocks Deportation of British Anti-Disinformation Campaigner Imran Ahmed Amid Free Speech Dispute 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
U.S. Urges Acceptance of Honduras Election Results as Nasry Asfura Declared President-Elect 
Argentina Congress Approves 2026 Budget Under Milei, Marking First Legislative Passage Since 2023 
The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwanda’s healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the agreement is the second deal finalized under the Trump administration’s “America First Global Health Strategy,” following a similar pact with Kenya earlier in the week. The initiative aims to help partner nations build sustainable, locally driven health programs while supporting global health security.
Under the new agreement, the U.S. will contribute up to $158 million to support Rwanda’s efforts to combat HIV/AIDS, malaria, and other infectious diseases. Funding will also enhance disease surveillance, emergency response capacity, and overall health-system resilience. In parallel, the government of Rwanda has committed to increasing its own domestic health spending by $70 million, signaling a long-term shift toward national ownership as American support gradually tapers.
U.S. officials highlighted that the partnership reflects a shared vision to save lives and improve Rwanda’s health infrastructure while contributing to broader regional stability. The announcement came shortly after Rwandan President Paul Kagame and Democratic Republic of the Congo President Felix Tshisekedi reaffirmed their commitment to a U.S.-brokered effort aimed at easing tensions in eastern Congo.
The deal will also expand Rwanda’s use of innovative healthcare technologies, including drone delivery of medical supplies through Zipline, a startup known for rapidly transporting blood, vaccines, and other critical products to remote areas. According to Rwanda’s foreign minister Oliver Nduhungirehe, the agreement demonstrates the nation’s determination to build a self-sufficient, adaptive, and technology-driven health system capable of meeting current and future challenges.
By aligning financial investment with emerging technologies and public-health goals, the partnership aims to strengthen care delivery, reduce disease burden, and reinforce Rwanda’s progress toward long-term health independence.
